These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1211000)

  • 1. Immunologic reactivity to incompatible blood group substances of the ABO system in scleroderma.
    Haustein UF; Beckmann I; Haustein B; Lewandowski A
    Acta Biol Med Ger; 1975; 34(8):1417-20. PubMed ID: 1211000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Genetic relationships between the HL-A system, the blood group systems (Rh, ABO) and the immune reactivity].
    Petrányi GG; Iványi P; Hollán Z
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1975; 102(1):29-34. PubMed ID: 50966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
    Galili U
    Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Periportal edema and necrosis as diagnostic histological features of early humoral rejection in ABO-incompatible liver transplantation.
    Haga H; Egawa H; Shirase T; Miyagawa A; Sakurai T; Minamiguchi S; Yamabe H; Manabe T; Tanaka K
    Liver Transpl; 2004 Jan; 10(1):16-27. PubMed ID: 14755773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humoral and cellular immunity in progressive systemic sclerosis.
    Sierakowski S; Bernacka K
    Med Interne; 1987; 25(4):233-8. PubMed ID: 3501150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hemagglutinins and immunoglobulins in surgical patients and blood donors (author's transl)].
    Peter H; Peter H; Werny D
    Med Klin; 1978 Apr; 73(17):615-20. PubMed ID: 642863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma exchange conditioning for ABO-incompatible renal transplantation.
    Winters JL; Gloor JM; Pineda AA; Stegall MD; Moore SB
    J Clin Apher; 2004; 19(2):79-85. PubMed ID: 15274200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in humoral immunity between a non-rejection group and a rejection group after ABO-incompatible renal transplantation.
    Ishida H; Tanabe K; Ishizuka T; Furusawa M; Miyamoto N; Ishikawa N; Shirakawa H; Shimmura H; Ishii D; Nozaki D; Setoguchi K; Toma H
    Transplantation; 2006 Mar; 81(5):665-71. PubMed ID: 16534466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial progressive systemic sclerosis (scleroderma): immunological analysis of two patients and six siblings from a single kindred.
    Soppi E; Lehtonen A; Toivanen A
    Clin Exp Immunol; 1982 Nov; 50(2):275-82. PubMed ID: 6217932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diversity and plasticity of the anti-DNA topoisomerase I autoantibody response in scleroderma.
    Henry PA; Atamas SP; Yurovsky VV; Luzina I; Wigley FM; White B
    Arthritis Rheum; 2000 Dec; 43(12):2733-42. PubMed ID: 11145031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic aspects of scleroderma.
    Needleman BW
    Curr Opin Rheumatol; 1992 Dec; 4(6):862-8. PubMed ID: 1457282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABO-incompatible liver transplantation with no immunological graft losses using total plasma exchange, splenectomy, and quadruple immunosuppression: evidence for accommodation.
    Hanto DW; Fecteau AH; Alonso MH; Valente JF; Whiting JF
    Liver Transpl; 2003 Jan; 9(1):22-30. PubMed ID: 12514769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects and problems of adult ABO-incompatible living donor liver transplantation using protocol of plasma exchange, intra-arterial infusion therapy, and anti-CD20 monoclonal antibody without splenectomy: case reports of initial experiences and results in Korea.
    Kim BW; Park YK; Kim YB; Wang HJ; Kim MW
    Transplant Proc; 2008 Dec; 40(10):3772-7. PubMed ID: 19100487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiles of antibodies to poly(ADP-ribose), left-handed Z-DNA, and other nuclear constituents in systemic lupus erythematosus and progressive systemic sclerosis.
    Kanai Y; Moroi Y; Yokohari R; Goto S
    Princess Takamatsu Symp; 1983; 13():93-100. PubMed ID: 6654833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABO-incompatible renal transplantation.
    Toma H
    Urol Clin North Am; 1994 May; 21(2):299-310. PubMed ID: 8178397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcome and accommodation in ABO incompatible kidney transplantation.
    Aikawa A; Ohara T; Arai K; Hadano T; Kawamura T; Sugiyama K; Muramatsu M; Itabashi Y; Kawada N; Kanai T; Hasegawa A
    Clin Transpl; 2004; ():135-42. PubMed ID: 16704146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a single center experience.
    Donauer J; Wilpert J; Geyer M; Schwertfeger E; Kirste G; Drognitz O; Walz G; Pisarski P
    Xenotransplantation; 2006 Mar; 13(2):108-10. PubMed ID: 16623802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different antibody patterns and different prognoses in patients with scleroderma with various extent of skin sclerosis.
    Giordano M; Valentini G; Migliaresi S; Picillo U; Vatti M
    J Rheumatol; 1986 Oct; 13(5):911-6. PubMed ID: 3546686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies against nuclear, nucleolar, and mitochondrial antigens in systemic sclerosis (scleroderma).
    Reimer G
    Rheum Dis Clin North Am; 1990 Feb; 16(1):169-83. PubMed ID: 2406806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cellular and humoral factors of immunogenesis of sytemic lupus erythematosus and systemic scleroderma].
    Demin AA; Galenok VA; Kolesnuk VV; Finchenko AF
    Klin Med (Mosk); 1973 Nov; 51(11):100-4. PubMed ID: 4787290
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.